CD274 and breast cancer: On the other hand, triple negative (TN) tumors have a grim prognosis but are also known to respond better to immunotherapy than other BC biologic subtypes based on higher TIL levels, more PD-L1/PD-1 activation, increased TMB and an increased neoantigen (neoAg) production [2,59,60,61,62,63].